Drawing for RHEALTH

USPTO serial 87978458

RHEALTH

Reviewed by CopyMark Law Group

Reg. 5597625Status 702Registered
Filing date
Status date
Registration date
Oct 30, 2018
Examiner
NOVAKOVIC, MIROSLAV
Law office
FILE DESTROYED

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with RHEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miguel C. Danielson

Miguel C. Danielson DANIELSON LEGAL LLCOne Mifflin Place, Suite 400Attn: Trademark AdministratorCAMBRIDGE, MA 02138

Goods and services

ClassDescriptionStatusFirst use
001Assays, reagents, and microparticles in the nature of reagents for clinical or medical laboratory, scientific or research purposes; Diagnostic and screening assays, reagents, and microparticles in the nature of reagents for clinical or medical laboratory, scientific or research useACTIVEMar 26, 2018
005Medical diagnostic assays, reagents, and micro particles in the nature of reagents for medical use, namely, for testing body fluids and cells; Medical diagnostic kits consisting of one or more types of medical diagnostic microparticles or reagents for testing body fluids and cells; Medical diagnostic kits consisting of one or more types of medical diagnostic microparticles and reagents for testing body fluids and cellsACTIVEMar 26, 2018
009Diagnostic apparatus for the detection of blood analytes for clinical or medical laboratory, scientific or research use; Diagnostic apparatus containing microparticles or reagents for the detection of analytes for clinical or medical laboratory, scientific or research use; Research tools in the nature of medical laboratory research instruments for obtaining and communicating one or more types of diagnostic information from a single patient's bodily fluid or cell sample, not for medical purposesACTIVEFeb 2, 2018
010Medical diagnostic apparatus for testing for the presence and concentration of analytes in bodily fluids and cells by obtaining and communicating one or more types of diagnostic information from a single patient's bodily fluid or cell sample; Medical diagnostic apparatus for processing a patient's bodily fluid or cell sample; disposable containers for processing, testing and analyzing a patient's bodily fluid or cell sampleACTIVEFeb 2, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 1, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 1, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 1, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 28, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Oct 30, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 30, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 26, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 25, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 10, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 10, 2018EX1GSOU EXTENSION 1 GRANTED—
Sep 10, 2018DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 16, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 30, 2018IUAFUSE AMENDMENT FILED—
Jul 30, 2018EXT1SOU EXTENSION 1 FILED—
Jul 30, 2018DRRRDIVISIONAL REQUEST RECEIVED—
Jul 30, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 30, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 30, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 5, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 27, 2017ALIEASSIGNED TO LIE—
Oct 11, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 11, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 11, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 11, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 18, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 18, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 18, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 11, 2017DOCKASSIGNED TO EXAMINER—
Jun 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 13, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance